非酒精性脂肪性肝病与代谢相关脂肪性肝病与代谢功能障碍相关脂肪性肝病：名称里有什么含义？
Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?
作者信息
Singh Shivaram P, Sudhamshu K C, Anirvan Prajna, Shrestha Ananta, Mahtab Mamun Al
机构信息
Department of Translational Research, Kalinga Gastroenterology Foundation, Cuttack, Odisha, India.
Department of Hepatology, Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal.
出版信息
Euroasian J Hepatogastroenterol. 2024 Jan-Jun;14(1):1-4. doi: 10.5005/jp-journals-10018-1424.
Abstract
Singh SP, Sudhamshu KC, Anirvan P, . Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name? Euroasian J Hepato-Gastroenterol 2024;14(1):1-4.
摘要
辛格·斯皮（Singh SP）、苏达姆舒·凯西（Sudhamshu KC）、阿尼尔万·P（Anirvan P）等。非酒精性脂肪性肝病与代谢相关脂肪性肝病与代谢功能障碍相关脂肪性肝病：名称背后有何含义？《欧亚肝脏胃肠病学杂志》2024年；14(1):1 - 4。
相似文献
1
Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?
Euroasian J Hepatogastroenterol. 2024 Jan-Jun;14(1):1-4. doi: 10.5005/jp-journals-10018-1424.
2
NAFLD vs MAFLD: South Asian NAFLD Patients don't Favor Name Change.
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S1-S4. doi: 10.5005/jp-journals-10018-1363.
3
Nonalcoholic Fatty Liver Disease in South Asia.
Euroasian J Hepatogastroenterol. 2016 Jul-Dec;6(2):154-162. doi: 10.5005/jp-journals-10018-1189. Epub 2016 Dec 1.
4
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
J Hepatol. 2024 Mar;80(3):419-430. doi: 10.1016/j.jhep.2023.11.004. Epub 2023 Nov 18.
5
Nonalcoholic Fatty Liver Disease in Diabetics: The Role of Hepatologist.
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S37-S40. doi: 10.5005/jp-journals-10018-1376.
6
Nonalcoholic Fatty Liver Disease: Time to Take the Bull by the Horns.
Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):47-51. doi: 10.5005/jp-journals-10018-1257. Epub 2018 May 1.
7
Examining the interim proposal for name change to steatotic liver disease in the US population.
Hepatology. 2023 May 1;77(5):1712-1721. doi: 10.1097/HEP.0000000000000043. Epub 2023 Jan 3.
8
Gender Differences in Nonalcoholic Fatty Liver Disease.
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S19-S25. doi: 10.5005/jp-journals-10018-1370.
9
New concept in fatty liver diseases.
Hepatol Res. 2024 Feb;54(2):125-130. doi: 10.1111/hepr.14004. Epub 2024 Jan 6.
10
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
Semin Liver Dis. 2024 Feb;44(1):35-42. doi: 10.1055/s-0044-1785196. Epub 2024 Mar 26.
引用本文的文献
1
MASLD, MLA Pesarattu and Other Developments.
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102465. doi: 10.1016/j.jceh.2024.102465. Epub 2024 Nov 22.
本文引用的文献
1
Expanding public health responses to non-communicable diseases: the NAFLD model of India.
Lancet Gastroenterol Hepatol. 2023 Nov;8(11):969-970. doi: 10.1016/S2468-1253(23)00312-6.
2
Is the change from NAFLD to MASLD driven by political correctness?
J Hepatol. 2024 Feb;80(2):e74-e76. doi: 10.1016/j.jhep.2023.08.027. Epub 2023 Sep 6.
3
99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical.
J Hepatol. 2024 Feb;80(2):e76-e77. doi: 10.1016/j.jhep.2023.08.026. Epub 2023 Sep 9.
4
Changing from NAFLD through MAFLD to MASLD: Similar prevalence and risk factors in a large Brazilian cohort.
J Hepatol. 2024 Feb;80(2):e72-e74. doi: 10.1016/j.jhep.2023.08.025. Epub 2023 Sep 9.
5
Letter to the Editor: NAFLD, MAFLD or MASLD? Cut the Gordian knot with "Ludwig disease".
Hepatology. 2024 Jan 1;79(1):E4. doi: 10.1097/HEP.0000000000000586. Epub 2023 Aug 30.
6
Reply: NAFLD, MAFLD, or MASLD? Cut the Gordian knot with "Ludwig disease".
Hepatology. 2024 Jan 1;79(1):E5-E6. doi: 10.1097/HEP.0000000000000587. Epub 2023 Aug 30.
7
INASL-SAASL Consensus Statements on NAFLD Name Change to MAFLD.
J Clin Exp Hepatol. 2023 May-Jun;13(3):518-522. doi: 10.1016/j.jceh.2022.12.011. Epub 2023 Jan 20.
8
A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD.
J Hepatol. 2023 Jul;79(1):4-5. doi: 10.1016/j.jhep.2023.05.003. Epub 2023 May 22.
9
Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019.
Front Nutr. 2022 Dec 21;9:1047129. doi: 10.3389/fnut.2022.1047129. eCollection 2022.
10
The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.
JMIR Public Health Surveill. 2022 Dec 12;8(12):e34809. doi: 10.2196/34809.
Zotero 插件